Answers are grounded in this paper and cite their sources.
Our claims data-based results suggest associations between transmucosal buprenorphine use and developing oral health problems among adults with OUD, underscoring the importance of targeted prospective research as well as counseling patients about this potential risk and ways to mitigate it, without unnecessarily deterring patients from this evidence-based treatment.
No takes yet. Share an insight, caveat, or question.
Tuan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: